OBJECTIVE: to validate the dynamic spectral imaging (DSI) colposcope's colour-coded map in discriminating high- from low-grade cervical lesions and non-neoplastic tissue. DESIGN: prospective, comparative, multicentre clinical trial. SETTING: the colposcopy clinics of three Dutch hospitals. POPULATION: women of 18 years or over with an intact cervix, referred for colposcopy. METHODS: during a 3-minute image acquisition phase, the DSI colposcope was used as a regular video colposcope: the colposcopist located and graded potential lesions based on conventional colposcopic criteria. Subsequently, a colour-coded map was calculated and displayed, representing localisation and severity of the cervical lesion. Biopsies were collected from all atypical sites, as identified by digital mapping and/or conventional colposcopy. Furthermore, one additional biopsy was taken. MAIN OUTCOME MEASURES: histologically confirmed high-grade cervical disease (CIN2+). RESULTS: in total 275 women were included in the study: 183 women were analysed in the 'according-to-protocol' (ATP) cohort and 239 women in the 'intention-to-treat' (ITT) cohort. In the ATP cohort, the sensitivity of DSI colposcopy to identify women with high-grade (CIN2+) lesions was 79% (95% CI 70-88) and the sensitivity of conventional colposcopy was 55% (95% CI 44-65) (P = 0.0006, asymptotic McNemar test). When the DSI colour-coded map was combined with conventional colposcopy, the sensitivity was 88% (95% CI 82-95). CONCLUSIONS: DSI colposcopy has a significantly higher sensitivity to detect cervical lesions than conventional colposcopy. If the colour-coded map is combined with conventional colposcopic examination, the sensitivity increases further.
OBJECTIVE: to validate the dynamic spectral imaging (DSI) colposcope's colour-coded map in discriminating high- from low-grade cervical lesions and non-neoplastic tissue. DESIGN: prospective, comparative, multicentre clinical trial. SETTING: the colposcopy clinics of three Dutch hospitals. POPULATION: women of 18 years or over with an intact cervix, referred for colposcopy. METHODS: during a 3-minute image acquisition phase, the DSI colposcope was used as a regular video colposcope: the colposcopist located and graded potential lesions based on conventional colposcopic criteria. Subsequently, a colour-coded map was calculated and displayed, representing localisation and severity of the cervical lesion. Biopsies were collected from all atypical sites, as identified by digital mapping and/or conventional colposcopy. Furthermore, one additional biopsy was taken. MAIN OUTCOME MEASURES: histologically confirmed high-grade cervical disease (CIN2+). RESULTS: in total 275 women were included in the study: 183 women were analysed in the 'according-to-protocol' (ATP) cohort and 239 women in the 'intention-to-treat' (ITT) cohort. In the ATP cohort, the sensitivity of DSI colposcopy to identify women with high-grade (CIN2+) lesions was 79% (95% CI 70-88) and the sensitivity of conventional colposcopy was 55% (95% CI 44-65) (P = 0.0006, asymptotic McNemar test). When the DSI colour-coded map was combined with conventional colposcopy, the sensitivity was 88% (95% CI 82-95). CONCLUSIONS: DSI colposcopy has a significantly higher sensitivity to detect cervical lesions than conventional colposcopy. If the colour-coded map is combined with conventional colposcopic examination, the sensitivity increases further.
Authors: Condon Lau; Jelena Mirkovic; Chung-Chieh Yu; Geoff P O'Donoghue; Luis Galindo; Ramachandra Dasari; Antonio de las Morenas; Michael Feld; Elizabeth Stier Journal: J Biomed Opt Date: 2013-07 Impact factor: 3.170
Authors: Maxime D Slooter; Henricus J M Handgraaf; Martin C Boonstra; Lily-Ann van der Velden; Shadhvi S Bhairosingh; Ivo Que; Lorraine M de Haan; Stijn Keereweer; Pieter B A A van Driel; Alan Chan; Hisataka Kobayashi; Alexander L Vahrmeijer; Clemens W G M Löwik Journal: Oral Oncol Date: 2018-01-09 Impact factor: 5.337
Authors: Sanaz Hariri Tabrizi; S Mahmoud Reza Aghamiri; Farah Farzaneh; Henricus J C M Sterenborg Journal: Lasers Med Sci Date: 2013-03-07 Impact factor: 3.161
Authors: Aarathi Cholkeri-Singh; Philip T Lavin; Christopher G Olson; Emmanouil Papagiannakis; Lori Weinberg Journal: J Low Genit Tract Dis Date: 2018-01 Impact factor: 1.925
Authors: Phuong Lien Tran; Bruno Kenfack; Eveline Tincho Foguem; Manuela Viviano; Liliane Temogne; Pierre-Marie Tebeu; Rosa Catarino; Anne-Caroline Benski; Pierre Vassilakos; Patrick Petignat Journal: Int J Womens Health Date: 2017-12-01
Authors: Sara A DeNardis; Philip T Lavin; Jeff Livingston; William R Salter; Nanette James-Patrick; Emmanouil Papagiannakis; Christopher G Olson; Lori Weinberg Journal: Int J Womens Health Date: 2017-09-28